person

Gianni T.

Country
Italy
Department
NA

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 43 partner sites.

Specializations

Hematologic Malignancies

The investigator concentrates on a spectrum of lymphoid and myeloid cancers.

  • Follicular Lymphoma
  • Chronic Lymphocytic Leukemia
  • Multiple Myeloma
  • Diffuse Large B-Cell Lymphoma
  • Acute Myeloid Leukemia

Research is conducted at IRCCS Ospedale Policlinico San Martino.

Solid Tumor Oncology

Focus includes major epithelial cancers across breast, lung, gastrointestinal and urologic sites.

  • Breast Cancer
  • Non‑Small Cell Lung Cancer
  • Colorectal Cancer
  • Urothelial Carcinoma
  • Renal Cell Carcinoma

Efforts aim to improve outcomes in advanced disease stages.

Autoimmune and Inflammatory Disorders

Extensive work on systemic and organ‑specific autoimmune conditions.

  • Systemic Lupus Erythematosus
  • Psoriatic Arthritis
  • Crohn's Disease
  • Ulcerative Colitis
  • Graft versus Host Disease

Therapeutic strategies target immune modulation.

Cardiovascular and Metabolic Diseases

Investigations address atherosclerotic disease, heart failure and metabolic risk.

  • Atherosclerotic Cardiovascular Disease
  • Heart Failure
  • Hypertension
  • Type 2 Diabetes Mellitus
  • Elevated Lipoprotein(a)

Studies explore novel approaches to reduce cardiovascular events.

Neurological and Neurodegenerative Conditions

Research spans neurodegenerative and neuroinflammatory disorders.

  • Alzheimer's Disease
  • Multiple Sclerosis
  • Parkinson's Disease
  • Amyotrophic Lateral Sclerosis
  • Epilepsy

Efforts focus on disease‑modifying interventions.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.